Traumatic brain injury opens blood-brain barrier to stealth liposomes via an enhanced permeability and retention (EPR)-like effect

被引:47
作者
Boyd, Ben J. [1 ,2 ]
Galle, Adam [3 ,4 ]
Daglas, Maria [3 ,4 ]
Rosenfeld, Jeffrey V. [5 ,6 ,7 ]
Medcalf, Robert [3 ,4 ]
机构
[1] Monash Univ, Monash Inst Pharmaceut Sci, Drug Delivery Disposit & Dynam, Parkville Campus,381 Royal Parade, Parkville, Vic 3052, Australia
[2] Monash Univ, Monash Inst Pharmaceut Sci, ARC Ctr Excellence Convergent Bionano Sci & Techn, Parkville, Vic 3052, Australia
[3] Monash Univ, Alfred Hosp, Australian Ctr Blood Dis, Melbourne, Vic, Australia
[4] Monash Univ, Cent Clin Sch, Mol Neurotrauma & Haemostasis, Parkville, Vic 3052, Australia
[5] Monash Univ, Alfred Hosp, Dept Surg, Melbourne, Vic, Australia
[6] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD 20814 USA
[7] Monash Univ, Monash Inst Med Engn, Melbourne, Vic, Australia
基金
澳大利亚研究理事会;
关键词
Albumin; blood-brain barrier; extravasation; stealth liposomes; traumatic brain injury; SERUM-ALBUMIN; MOLECULAR-WEIGHT; MICE; DENDRIMER; FASUDIL; EDEMA; MODEL;
D O I
10.3109/1061186X.2015.1034280
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The opening of the tight junctions in the blood-brain barrier (BBB) following traumatic brain injury (TBI) is hypothesized to be sufficient to enable accumulation of large drug carriers, such as stealth liposomes, in a similar manner to the extravasation seen in tumor tissue via the enhanced permeability and retention (EPR) effect. The controlled cortical impact model of TBI was used to evaluate liposome accumulation in mice. Dual-radiolabeled PEGylated liposomes were administered either immediately after induction of TBI or at increasing times post-TBI to mimic the likely clinical scenario. The accumulation of radiolabel in the brain tissue ipsilateral and contralateral to the site of trauma, as well as in other organs, was evaluated. Selective influx of liposomes occurred at 0-8h after injury, while the barrier closed between 8 and 24hr after injury, consistent with reports on albumin infiltration. Significantly enhanced accumulation of liposomes occurred in mice subjected to TBI compared to anaesthetized controls, and accumulation was greater in the injured versus the contralateral side of the brain. Thus, stealth liposomes show potential to enhance drug delivery to the site of brain injury with a wide range of encapsulated therapeutic candidates.
引用
收藏
页码:847 / 853
页数:7
相关论文
共 26 条
[1]   SUBCUTANEOUS ADMINISTRATION OF LIPOSOMES - A COMPARISON WITH THE INTRAVENOUS AND INTRAPERITONEAL ROUTES OF INJECTION [J].
ALLEN, TM ;
HANSEN, CB ;
GUO, LSS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1150 (01) :9-16
[2]   Cationic poly-L-lysine dendrimers: Pharmacokinetics, biodistribution, and evidence for metabolism and bioresorption after intravenous administration to rats [J].
Boyd, Ben J. ;
Kaminskas, Lisa M. ;
Karellas, Peter ;
Krippner, Guy ;
Lessene, Romina ;
Porter, Christopher J. H. .
MOLECULAR PHARMACEUTICS, 2006, 3 (05) :614-627
[3]   Tumour-Specific Uptake of Anti-Cancer Drugs: The Future is Here [J].
Caraglia, Michele ;
Marra, Monica ;
Misso, Gabriella ;
Lamberti, Monica ;
Salzano, Giuseppina ;
De Rosa, Giuseppe ;
Abbruzzese, Alberto .
CURRENT DRUG METABOLISM, 2012, 13 (01) :4-21
[4]   Biological evaluation of polyester dendrimer:: Poly(ethylene oxide) "Bow-Tie" hybrids with tunable molecular weight and architecture [J].
Gillies, Elizabeth R. ;
Dy, Edward ;
Frechet, Jean M. J. ;
Szoka, Francis C. .
MOLECULAR PHARMACEUTICS, 2005, 2 (02) :129-138
[5]   The blood-brain barrier/neurovascular unit in health and disease [J].
Hawkins, BT ;
Davis, TP .
PHARMACOLOGICAL REVIEWS, 2005, 57 (02) :173-185
[6]   Encapsulation of an antivasospastic drug, fasudil, into liposomes, and in vitro stability of the fasudil-loaded liposomes [J].
Ishida, T ;
Takanashi, Y ;
Doi, H ;
Yamamoto, I ;
Kiwada, H .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 232 (1-2) :59-67
[7]   The impact of molecular weight and PEG chain length on the systemic pharmacokinetics of PEGylated poly L-lysine dendrimers [J].
Kaminskas, Lisa M. ;
Boyd, Ben J. ;
Karellas, Peter ;
Krippner, Guy Y. ;
Lessene, Romina ;
Kelly, Brian ;
Porter, Chrisiopher J. H. .
MOLECULAR PHARMACEUTICS, 2008, 5 (03) :449-463
[8]   A comparison of changes to doxorubicin pharmacokinetics, antitumor activity, and toxicity mediated by PEGylated dendrimer and PEGylated liposome drug delivery systems [J].
Kaminskas, Lisa M. ;
McLeod, Victoria M. ;
Kelly, Brian D. ;
Sberna, Gian ;
Boyd, Ben J. ;
Williamson, Mark ;
Owen, David J. ;
Porter, Christopher J. H. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2012, 8 (01) :103-111
[9]   Differences in Colloidal Structure of PEGylated Nanomaterials Dictate the Likelihood of Accelerated Blood Clearance [J].
Kaminskas, Lisa M. ;
Mcleod, Victoria M. ;
Porter, Christopher J. H. ;
Boyd, Ben J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (11) :5069-5077
[10]   Pharmacokinetics and Tumor Disposition of PEGylated, Methotrexate Conjugated Poly-L-lysine Dendrimers [J].
Kaminskas, Lisa M. ;
Kelly, Brian D. ;
McLeod, Victoria M. ;
Boyd, Ben J. ;
Krippner, Guy Y. ;
Williams, Elizabeth D. ;
Porter, Christopher J. H. .
MOLECULAR PHARMACEUTICS, 2009, 6 (04) :1190-1204